BioSpace News Archive

Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation using its PROTAC ® Discovery Engine, today announced that the underwriters of its previously announced underwritten public offering of common stock, which closed on December 18, 2020, have exercised in full their option to purchase additional shares of common stock at the public offering price, less underwr

VNM USA, in partnership with PrecisionOS™, foresees the next decade of surgical education being driven largely by immersive virtual reality training modules.

REDWOOD CITY, Calif., Dec. 28, 2020 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq:RZLT), focused on advancing therapies for rare, metabolic and life-threatening diseases, announced today the appointment of IssuerDirect as the Company’s registrar and transfer agent and shareholder support provider. IssuerDirect will now be responsible for all transfers of Rezolute shares rather than VStock Transfer, LLC. Shareholders need take no action related to this transaction. About Rezolute, Inc. Rezol

GenMark Diagnostics, Inc., a leading provider of automated, multiplex molecular diagnostic testing systems, announced that the company plans to participate in two upcoming investor conferences.

Hologic to Webcast Presentation at the 39 th Annual J.P. Morgan Healthcare Conference

CARLSBAD, Calif., Dec. 28, 2020 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced that its management will present at the upcoming J.P. Morgan 39 th Annual Healthcare Conference on Wednesday, January 13, 2021 at 10:00 a.m. Eastern Time. A live, audio-only webcast of the presentation may be accessed by visiting ir. acutusmedical.com . A replay of th